Global Biochip Scanner Market Is Projected To Grow At A CAGR Of Over 11.20%

Home » Industry Update » Global Biochip Scanner Market Is Projected To Grow At A CAGR Of Over 11.20%
Information and Communications Technology

The latest market report published by Credence Research, Inc. “Global Biochip Scanner Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”. The global biochip scanner market generated revenue of around USD 13,184.2 million in 2021 and is anticipated to grow a CAGR of over 11.20% during the forecast period from 2022 to 2028 to reach around USD 24,927.72 million in 2028.

Over the last few years, the biochip scanner market has grown significantly. Its growth is mainly driven by the growing importance of biochip scanners in various biomedical applications; ongoing research and development activities in large-scale genomics and proteomics, advances in nanotechnology; growing prevalence of chronic disorders, especially among the rapidly aging elderly population, across the globe; and increasing interest among consumers in maintaining healthy lifestyles.

The global biochip scanner market is bifurcated into Type, End User, and Geography. Based on type, the market is categorized into DNA chips, lab-on-a-chip, protein chips, cancer diagnosis and treatment, gene expression, single nucleotide polymorphism (SNP) genotyping, genomics, drug discovery, others (agricultural biotechnology, proteomics, expression profiling, high throughput screening). On the basis of end users, the global market is segmented into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, and academic & research institutes. Based on geography, the market is segmented as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Browse Global Biochip Scanner Market report-

In 2021, North America dominated the global biochip scanner market and accounted for a major market revenue share in terms of value. The US and Canada are the key countries contributing to the market’s growth in the biomedical field. This is due to the technological advancements taking place in the fields of medicine within these countries.  As research laboratories adopt biochip scanners and biochip scanning technology is increasingly used in drug development, clinical research, toxicology studies, diagnostics and clinical trials, the market is flourishing in North America.

Why to Buy This Report-

  • The report provides a qualitative and quantitative analysis of the global biochip scanner market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, base year- 2021, and forecast period 2022-2028.
  • The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level
  • In-depth analysis of the global biochip scanner market segmentation based on the type and end user.
  • The global biochip scanner market report also includes analyzing the global, regional, and country levels, along with key market trends, significant players analysis, market growth strategies, and key application areas.

The Global Biochip Scanner Market is Segmented into:

Research Period 2016-2028
Base Year2021
Forecast Period2022 – 2028
Historical Year2016 – 2021
Unit USD Million
SegmentationBy Product Type (2016–2028; US$ Mn)
By Application (2016–2028; US$ Mn)
By End-use (2016–2028; US$ Mn)
By Geography Segment (2016–2028; US$ Mn)


Contact Us Form

– Trusted By –

Pepsi, LG, Nestle
Motorola, Honeywell, Johnson and Jonson
LG Chem, SIEMENS, Pfizer
Uniliveer, Samsonite, QIAGEN